Zynerba Pharmaceuticals Inc. (ZYNE) rose 5.84% or 0.42 to $7.61. It is near to 246914 shares traded, which is 49.6% compare to the average total volume 497860. The market cap of ZYNE is $134.12 million. The year to date change is -38.83%. The 52 week price range is from $5.59 to $15.13. Price of ZYNE have changed -5.27% during last week. It have changed 8.12% over last month, -25.26% over last 3 months, -28.24% over last 6 months and -24.08% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 7.18. It is -5.65% below current price. The 200-day Moving Averages for ZYNE is 9.48. It is 24.57% above current price. The 52-week High is 15.13. It is 98.82% from the current price. The 52-week Low is 5.59. It is -26.54% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 3.17 on 2018-09-28. Short % to float is 16.61%. There are some statistics of ZYNE. It is has market cap $134.12 million. The share outstanding is 17.62 million. The average volume is 497860. The percent of top 15 Institution holding is 18.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -72.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -61.23%.